Skip to main content
Clinical Trials/JPRN-UMIN000010723
JPRN-UMIN000010723
Completed
Phase 2

Therapeutic Effects of Neurofeedback in Neurological Disorders - Therapeutic Effects of Neurofeedback in Neurological Disorders

Dept. of Neurology, Osaka University Graduate School of Medicine0 sites117 target enrollmentJune 15, 2013

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dept. of Neurology, Osaka University Graduate School of Medicine
Enrollment
117
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 15, 2013
End Date
February 21, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dept. of Neurology, Osaka University Graduate School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Exclusion criteria includes: 1\) severe cognitive dysfunction (MMSE\<20\). 2\) severe carotid or intracerebral arterial stenosis (ICAstenosis\>90% or MCA/ACA/PCA stenosis \>75%) 3\) Patients with large cortical lesion (\> 1/3 of MCA territory). 4\) unstable general condition. 5\) undiagnosed patients. 6\) with poor visual acuity (\<0\.05\) 7\) unable to understand examiners' order 8\) with severe infection. 9\) with scalp dermatitis 10\) pregnant or lactating woman 11\) being considered not to be enrolled in this study by attending physician.

Outcomes

Primary Outcomes

Not specified

Similar Trials